Doctrine page

Compulsory Licences: The Scheme

Is Chapter XVI a complete code on abuse of patent rights?

Chapter XVI is a complete code in itself on abuse of status as a patentee, sections 82 to 94 dealing with working of patents, compulsory licences and revocation for non-working.

Doctrine last updated on 14 November 2026

Cite this page

Compulsory Licences: The Scheme, Ali on Patents, www.aop.onl/compulsory-licence

1The grant of a patent confers limited monopoly on the patentee to the exclusion of others. Though the law permits this, it also takes into account the fact that the monopoly granted through a patent may be abused and hence, provides for certain restrictions to its enjoyment. (See Patents Act 1970, ss 140 and 141.) The grant of compulsory licence is one such restriction imposed on the absolute exploitation of a patent. Restrictions on the monopoly existed even in the early days, as is evident from the Statute of Monopolies which made a patent void if the grant was prejudicial or inconvenient to the King’s subjects and provided for revocation of a patent on the ground that the patentee neglected to work the patent. (See Hatschek’s Patent [1909] 2 Ch 68, p 91.) (Wyndham Hulme, ‘On the Consideration of the Patent Grant, past and present’, 13 LQR 313, p 316.)

2In the United Kingdom, the power to grant relief such as compulsory licences, in case of abuse of monopolies caused by patents, was first given to Board of Trade (1883). The power was then transferred to the Judicial Committee of the Privy Council (1902), and then to the court (1907) and finally to the Comptroller (1919). (See Brownie Wireless Co Ltd’s Applications (1929) 46 RPC 457, pp 469-471. For the historical development of compulsory licences see ch 11, Terrell on the Law of Patents, fifteenth edn, 2000, p 338.) The UK Patents Act 1949 expanded the grounds on which a compulsory licence could be obtained, and also provided for ’licence of right’. The provisions of the UK Patents Act 1949 were similar to the Patents Act. It provided for the grant of compulsory licence in case of inadequate working of the invention, or oppressive conduct by the patentee. (UK Patents Act 1949, s 37.) It also provided for compulsory licence for food, medicines, surgical or curative devices. (Ibid, s 41.) The above provisions were not worked often. As a result the special provision for food, medicines etc no longer exists in the UK Patents Act 1977. (See Terrell on the Law of Patents, fifteenth edn, 2000, p 340. See also Hoffman-La Roche & Co AG v Inter Continental Pharmaceuticals Ltd (1965) RPC 226, [1965] Ch 795; Hoffman- La Roche & Co AG’s Patent (1969) RPC 504; Hoffman-La Roche & Co AG’s Patent [1970] FSR 225 for instances relating to licences in respect of the drugs chlordiazepoxide, imipramine hydrochloride and quinazoline.)

3In India, the provisions on compulsory licensing were introduced into the Patents Act pursuant to the recommendations made by the Ayyangar Committee. (See Justice N Rajagopala Ayyangar, ‘Report on the Revision of the Patent Laws’, September 1959, para 125-167.) Identifying the fact that the abuse of patent rights has been a matter of common concern for many countries, the Committee observed: (Ibid, p 50, para 125.)

India is not unique in having to face this problem of patents for vital inventions being owned by foreigners who evince no desire to work them within the country. The problem is common to all under-developed countries which have adopted the patent system of rewarding inventors. Two means for redressing this handicap have generally been adopted, namely (1) compulsory working, with revocation of the patent in the event of non-working, and (2) compulsory licensing on terms of royalty settled by an outside authority where the parties do not agree. Michel observes: ‘The compulsory working system originated in the French Law of 1791 and was adopted by practically all the principal patent systems excepting that of United States at present. (Michel on Principal National Patent Systems, vol 1, pp 14-15.) The important feature of this system was the invalidation of patent if the inventor failed to work his invention within two years from the date of the grant unless he could justify his inaction…The requirement of working the patented invention was originally a prerequisite to patent protection in England and even in the United States. If, in the further development of the US patent system, it was forgotten, the reason for this is to be found in the economic condition and a leaf as to the future trend may perhaps be taken from the development of the British patent system’.

4The predominant purpose behind the grant of a compulsory licence is to ensure the supply of the patented invention in the Indian market. (Patents Act 1970, s 90(1)(vii). See also TRIPS Agreement, art 31(f).) Patents are not granted to enable the patentee to enjoy a monopoly by importing the patented articles into India. The Patents Act makes working of the invention in India an important requirement. (Ibid, s 83(a).) At the same time, the effort expended by the patentee in inventing the patented article, the expenditure incurred in research and development, and in obtaining and keeping the patent in force cannot be disregarded. The provisions on compulsory licensing endeavours to secure that the articles manufactured under the patent shall be available to the public at the lowest prices consistent with the patentees deriving a reasonable advantage from their patent rights. (Ibid, s 92(1)(ii).)

5The provisions on compulsory licences are detailed in ch XVI of the Patents Act. This chapter was substantially amended by the Patents (Amendment) Act 2002. Before the said amendment, the chapter consisted of ss 82 to 98 and included provisions on ‘Licences of right’. The Patents (Amendment) Act 2002 omitted the provisions on ‘Licences of right’ and resultantly the chapter and the Patents Act now remains devoid of ss 95 to 98. Presently, ss 82 to 94 deal with working of patents, compulsory licences and revocation for non-working. A brief statement of law before the Patents (Amendment) Act 2002, which came into effect from 20 May 2003, will be helpful in understanding the changes brought about by the said amendment which are largely in compliance with the provisions of the TRIPS Agreement.

6In Monsanto Holdings v Competition Commission of India (2023) the Division Bench of the Delhi High Court held that “the inquiry that the CCI proposes to conduct in respect of an assertion of patent rights is nearly identical to that which the Controller will conduct under Chapter XVI of the Patents Act” (para 49) and that “Chapter XVI of the Patents Act is a complete code in itself on all issues pertaining to unreasonable conditions in agreements of licensing of patents, abuse of status as a patentee, inquiry in respect thereof and relief that is to be granted therefor.” (para 52) The Bench added that “The legislature, in its wisdom, after enacting the Competition Act, amended the Patents Act to introduce Chapter XVI and has chosen to keep the effect of the orders of the Controller in personam.” (para 64)

7The Patents (Amendment) Act 2002 brought about substantial changes to the earlier provisions of ch XVI. Section 83 deals with the general principles applicable to the working of patented inventions. Before the said amendment, the said section had only two clauses, ie, cll (a) and (b). The Patents (Amendment) Act 2002 introduced cll (c) to (g). Section 84 as it existed before the amendment provided for the applicant to pray ‘for the grant of a compulsory licence to work the patented invention’. (Patents Act 1970, s 84(1) (as it was before the Patents (Amendment) Act 2002).) The present provision refers to ‘grant of compulsory licence on patent’. Section 85 of the Patents Act, as it was before the amendment, now figures as s 84(6). The earlier provision was devoid of cl (iv). Sections 86, 87 and 88 of the Patents Act, in its original form, dealt with ‘Licences of right’. The provisions on ‘Licences of right’ were completely removed by the Patents (Amendment) Act 2002.

8Section 90 of the Patents Act, in its original form, dealt with situations where the reasonable requirements of the public were deemed not to have been satisfied. The said section as it was before the amendment, now figures as s 84(7) with some modifications. Section 84(7) now contains cl (c), which deals with conditions imposed by the patentee ’to provide exclusive grant back, prevention to challenges to the validity of patent or coercive package licensing’. Importantly, the Patents Act no longer contains the provision on importation which existed as s 90(d) of the Act before the amendment. The relevant provision read:

  1. When reasonable requirements of the public deemed not satisfied.—

For the purposes of section 84, 86 and 89, the reasonable requirements of the public shall be deemed not to have been satisfied –

…

(d) if the demand for the patented article in India is being met to a substantial extent by importation from abroad by – (i) the patentee or persons claiming under him; or (ii) persons directly or indirectly purchasing from him; or (iii) other persons against whom the patentee is not taking or has not taken proceedings for infringement.

9Sections 91, 92, 93, 94, 95, 96, 97 and 98 of the Patents Act before the said amendment now appear as ss 86, 87, 88, 89, 90, 91, 92 and 93 respectively. The said amendment introduced s 94 which deals with termination of compulsory licences. The Patents (Amendment) Act 2005 introduced s 92A which further provides for compulsory licence for export of patented pharmaceutical products.

10Article 27(1) of the TRIPS Agreement provides that ‘patents shall be available and patent rights enjoyable without discrimination as to the place of invention, the field of technology and whether products are imported or locally produced’. As a part of the principle of national treatment enshrined in the WTO Agreement as well as the TRIPS Agreement, the compulsory licensing provisions have to be applied equally without any discrimination between persons who choose to import and persons who choose to manufacture domestically.

11Article 31 of the TRIPS Agreement provides for certain conditions to be taken into account where the law permits certain kinds of uses without the authorisation of the right holder, which includes the grant of compulsory licences. Article 40 of the TRIPS Agreement allows member countries to take measures on those acts of the right holder which may restrain competition. The member countries may specify in their legislation such licensing practices or conditions pertaining to intellectual property rights which may have adverse effect on trade, and may impede the transfer and dissemination of technology. The member may adopt measures to prevent or control such practices which may include exclusive grant back conditions, conditions preventing challenges to validity and coercive package licensing, in the light of the relevant laws and regulations of that member.

12Sections 46 to 54 of the UK Patents Act 1977 deal with licences of right and compulsory licences, and replaced ss 37 to 45 of the UK Patents Act 1949. The provisions on licences of right offer no comparative insight in the light of the removal of the corresponding provisions from the Patents Act, but the principles for the grant of licences of right and compulsory licences have been the same. The UK Patents Act differs with the Patents Act in that it has abolished provisions with regard to compulsory licences for food and medicines which existed earlier, whereas the Patents Act has introduced special provisions for export of patented pharmaceutical products. (Patents Act 1970, s 92A.) The UK Patents Act provides for separate provisions for the grant of compulsory licences for patents held by WTO proprietors and by others who are not WTO members. This distinction does not exist under the Patents Act.

13The applicant for a compulsory licence may defend himself in an action of infringement against him by denying such infringement or questioning the validity of a patent and seeking its revocation, while his application for compulsory licensing is in progress. (See Halcon SD Group Inc’s Patents (1989) RPC 1, p 19. See also EI Du Pont (Blades’) Patent (Licence of Right) (1988) RPC 479, p 490.) It follows that the patentee in an infringement suit may seek an injunction against the defendant who may be a compulsory licensee. (See Dyrlund Smith A/S v Turberville Smith Ltd [1998] FSR 774 (CA), a case pertaining to a registered design.) The court will be reluctant to stay an action of infringement pending the outcome of an application for compulsory licence. (See Pfizer Corp v DDSA Pharmaceuticals Ltd (1966) RPC 44, p 46.) Conversely, an application for compulsory licence may be stayed pending the outcome of an infringement suit. (See Halcon SD Group Inc’s Patents (1989) RPC 1, p 25.) Under s 110, the licensee can take steps against infringement. In certain circumstances, the holders of compulsory licences will have the right to sue for infringement.

14In Bayer v Union of India (2014) the Bombay High Court recorded that “We are informed at the Bar that it is for the first time after India became a signatory to Trade Related Aspects of Intellectual Property Rights (TRIPS) followed by the Doha Declaration in 2001 and the amendments to the said Act in 2003 and 2005 that the issue of compulsory licence has arisen for consideration” (para 2), and held that “the entire basis of grant of compulsory licence is based on the objective that patented article is made available to the society in adequate numbers and at a reasonable price. These are matters of public interest. The law of patent is a compromise between interest of the inventor and the public.” “Public interest is and should always be fundamental in deciding a lis between the parties while granting a compulsory licence for medicines/drugs.” (para 19)

15In Novartis v Cipla (2015) the Delhi High Court held that “Any party who intends to obtain compulsory license under these provisions obviously has to acknowledge the validity of patent” (para 81), and that “the general principles stated in the said chapter are operative for the purposes of the exercise of the powers under the Chapter XVI” (para 98(a)), but “It does not follow that merely because section 48 rights are subject to other provisions of the Act and section 83 provides general principles which are applicable to working of the patented inventions which are applicable to exercise of the powers under chapter XVI would equally be applicable to the proceedings for infringement of the patent and/ or the counter claim challenging the validity of the patent which are governed by the distinct provisions under section 104 and section 107 of the Patents Act.” (para 98) The grounds for a compulsory licence “could be urged before the relevant authority which will consider the matter and cannot be imported as a matter of defence to the suit for infringement” (para 99), and “this court while hearing the application seeking the grant of the interim injunction may not refuse the injunction by forming any opinion solely on the ground as to whether the patented invention is sufficiently worked upon in India or whether the same is available to the public in reasonably affordable prices” (para 100). “Merely the grounds and conditions stipulated under section 83 and 84 of the Act do not absolve the defendant to infringe the registered patent.” (para 131)

Provisions and topics

Provisions
Topics

Cases on this page

Case page

Monsanto Holdings Pvt Ltd v Competition Commission of India (2023)

High Court of Delhi·13 July 2023

Case page

Bayer Corporation v Union of India (2014)

High Court of Bombay·15 July 2014

Case page

Novartis AG v Cipla (2015)

High Court of Delhi·9 January 2015

Case page

Imperial Chemical Industries Ltd v Controller General of Patents, Designs and Trade Mark (1977)

High Court of Calcutta·4 July 1977

See also

Doctrine page

Reasonably Affordable Price

Can a compulsory licence be granted in India because a patented medicine is too expensive?

Doctrine page

Compulsory Licence for Export

Can a compulsory licence be granted in India solely to export patented medicines?

Doctrine page

Procedure on a Compulsory Licence Application

What is the procedure on an application for a compulsory licence under section 84?

Doctrine page

National Emergencies and Public Health

Can a compulsory licence be granted quickly in a national emergency or public health crisis?

Doctrine page

Terms of a Compulsory Licence

What terms and royalty does the Controller settle in a compulsory licence?

Doctrine page

Reasonable Requirements of the Public

Does a patentee have to meet the demand for a patented medicine in full?

Doctrine page

Not Worked in the Territory of India

Must a patent be manufactured in India to be worked in the territory of India?

Doctrine page · Written by Prof. Feroz Ali

www.aop.onl/compulsory-licence